AU2758495A - Energy substrates - Google Patents

Energy substrates

Info

Publication number
AU2758495A
AU2758495A AU27584/95A AU2758495A AU2758495A AU 2758495 A AU2758495 A AU 2758495A AU 27584/95 A AU27584/95 A AU 27584/95A AU 2758495 A AU2758495 A AU 2758495A AU 2758495 A AU2758495 A AU 2758495A
Authority
AU
Australia
Prior art keywords
energy substrates
substrates
energy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27584/95A
Inventor
Rolf Ekroth
Jan Wernerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of AU2758495A publication Critical patent/AU2758495A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
AU27584/95A 1994-06-10 1995-06-09 Energy substrates Abandoned AU2758495A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9402027A SE9402027D0 (en) 1994-06-10 1994-06-10 Energy substrates
SE9402027 1994-06-10
PCT/SE1995/000698 WO1995034301A1 (en) 1994-06-10 1995-06-09 Energy substrates

Publications (1)

Publication Number Publication Date
AU2758495A true AU2758495A (en) 1996-01-05

Family

ID=20394327

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27584/95A Abandoned AU2758495A (en) 1994-06-10 1995-06-09 Energy substrates

Country Status (4)

Country Link
AU (1) AU2758495A (en)
SE (1) SE9402027D0 (en)
WO (1) WO1995034301A1 (en)
ZA (1) ZA954775B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859001A (en) 1996-01-11 1999-01-12 University Of Florida Research Foundation, Inc. Neuroprotective effects of polycyclic phenolic compounds
US5880098A (en) * 1996-04-12 1999-03-09 Pharmacia & Upjohn Aktiebolag Therapeutic treatment
PL369552A1 (en) * 2004-08-12 2006-02-20 Sgp & Sons Ab Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions
WO2006127902A1 (en) * 2005-05-26 2006-11-30 Ben O'mar Arrington Preservation solution for organs and biological tissues
PL379512A1 (en) * 2006-04-21 2007-10-29 Sgp & Sons Ab New methods and their application
WO2009005464A1 (en) * 2007-07-02 2009-01-08 Entress Ab New use of known pharmacologically active chemical compounds
CN109417016B (en) * 2016-05-01 2022-06-03 加州大学董事会 Glutaric acid compounds for the treatment of ischemia-reperfusion injury

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3168925D1 (en) * 1980-12-23 1985-03-28 Koehler Chemie Dr Franz Protective solution for heart and kidney, and manufacturing process
AU596880B2 (en) * 1986-09-17 1990-05-17 Clintec Nutrition Company Liquid nutritional compositions
SE8704217D0 (en) * 1987-10-29 1987-10-29 Vinnars Erik Ab AMINO ACID COMPOSITION FOR PARENTERAL NUTRITION
US4988515A (en) * 1988-01-28 1991-01-29 The Regents Of The Univ. Of Calif. Cardioplegic solution
DE3943424A1 (en) * 1989-12-30 1991-07-04 Nephro Medica Pharma Solns. for intravenous nutrition - contg. alpha-keto acids, for patients with kidney conditions, avoids nitrogen cpd. build-up
SE9201584D0 (en) * 1992-05-20 1992-05-20 Vinnars Erik Ab USE OF ALPHA KETOGLUTARATE

Also Published As

Publication number Publication date
SE9402027D0 (en) 1994-06-10
WO1995034301A1 (en) 1995-12-21
ZA954775B (en) 1996-02-08

Similar Documents

Publication Publication Date Title
AU3304795A (en) Bisresorcinyltriazines
AU2832295A (en) Cytoanalyzer
AU3304995A (en) 2-Hydroxyphenyltriazines
AU1413595A (en) Windmill
AU2837895A (en) Thiazine- or thiazepine-derivatives
AU4131596A (en) Polyglycomers
AU4044795A (en) Handleset
AU2308295A (en) Heterocyclylbenzonitriles
AU1963395A (en) Boom-structure
AU2758495A (en) Energy substrates
AU4029295A (en) Thienopyridones
AU7469594A (en) Poop-scoop
AU3166195A (en) Acylimidazopyridines
AU6127096A (en) Solar geo-stellar planisphere
AU4590996A (en) Boekomslag
AUPM365494A0 (en) Pre-chiller
AU3098695A (en) Energy sources
AU3166095A (en) Benzylimidazopyridines
AU4039795A (en) Solar still
AU3646695A (en) High-efficiency solar panel
AU1603595A (en) Meso-azanoradamantanes
AU3446995A (en) Biodestumping
AU2411395A (en) Hydrocopter
AU3417395A (en) Hydro-ethano-indeno-pyridines
AUPM999894A0 (en) Solar still